236 related articles for article (PubMed ID: 23263784)
1. Critical solvent properties affecting the particle formation process and characteristics of celecoxib-loaded plga microparticles via spray-drying.
Wan F; Bohr A; Maltesen MJ; Bjerregaard S; Foged C; Rantanen J; Yang M
Pharm Res; 2013 Apr; 30(4):1065-76. PubMed ID: 23263784
[TBL] [Abstract][Full Text] [Related]
2. Pharmaceutical microparticle engineering with electrospraying: the role of mixed solvent systems in particle formation and characteristics.
Bohr A; Wan F; Kristensen J; Dyas M; Stride E; Baldursdottír S; Edirisinghe M; Yang M
J Mater Sci Mater Med; 2015 Feb; 26(2):61. PubMed ID: 25631263
[TBL] [Abstract][Full Text] [Related]
3. Preparation of polylactide-co-glycolide nanoparticles incorporating celecoxib and their antitumor activity against brain tumor cells.
Kim TH; Jeong YI; Jin SG; Pei J; Jung TY; Moon KS; Kim IY; Kang SS; Jung S
Int J Nanomedicine; 2011; 6():2621-31. PubMed ID: 22114493
[TBL] [Abstract][Full Text] [Related]
4. Modulating protein release profiles by incorporating hyaluronic acid into PLGA microparticles Via a spray dryer equipped with a 3-fluid nozzle.
Wan F; Maltesen MJ; Andersen SK; Bjerregaard S; Baldursdottir SG; Foged C; Rantanen J; Yang M
Pharm Res; 2014 Nov; 31(11):2940-51. PubMed ID: 24867422
[TBL] [Abstract][Full Text] [Related]
5. Celecoxib-loaded poly(D,L-lactide-co-glycolide) nanoparticles prepared using a novel and controllable combination of diffusion and emulsification steps as part of the salting-out procedure.
McCarron PA; Donnelly RF; Marouf W
J Microencapsul; 2006 Aug; 23(5):480-98. PubMed ID: 16980271
[TBL] [Abstract][Full Text] [Related]
6. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
Witschi C; Doelker E
J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
[TBL] [Abstract][Full Text] [Related]
7. Sustained release of etanidazole from spray dried microspheres prepared by non-halogenated solvents.
Wang FJ; Wang CH
J Control Release; 2002 Jun; 81(3):263-80. PubMed ID: 12044566
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
Ayalasomayajula SP; Kompella UB
Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
[TBL] [Abstract][Full Text] [Related]
9. Release profile and characteristics of electrosprayed particles for oral delivery of a practically insoluble drug.
Bohr A; Kristensen J; Dyas M; Edirisinghe M; Stride E
J R Soc Interface; 2012 Oct; 9(75):2437-49. PubMed ID: 22535697
[TBL] [Abstract][Full Text] [Related]
10. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
11. Respirable PLGA microspheres containing rifampicin for the treatment of tuberculosis: manufacture and characterization.
O'Hara P; Hickey AJ
Pharm Res; 2000 Aug; 17(8):955-61. PubMed ID: 11028941
[TBL] [Abstract][Full Text] [Related]
12. One-step production of protein-loaded PLGA microparticles via spray drying using 3-fluid nozzle.
Wan F; Maltesen MJ; Andersen SK; Bjerregaard S; Foged C; Rantanen J; Yang M
Pharm Res; 2014 Aug; 31(8):1967-77. PubMed ID: 24549821
[TBL] [Abstract][Full Text] [Related]
13. Water-free microencapsulation of proteins within PLGA microparticles by spray drying using PEG-assisted protein solubilization technique in organic solvent.
Mok H; Park TG
Eur J Pharm Biopharm; 2008 Sep; 70(1):137-44. PubMed ID: 18515053
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-based topical ophthalmic formulations for sustained celecoxib release.
Ibrahim MM; Abd-Elgawad AE; Soliman OA; Jablonski MM
J Pharm Sci; 2013 Mar; 102(3):1036-53. PubMed ID: 23293035
[TBL] [Abstract][Full Text] [Related]
15. Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.
Kang Y; Wu J; Yin G; Huang Z; Yao Y; Liao X; Chen A; Pu X; Liao L
Eur J Pharm Biopharm; 2008 Sep; 70(1):85-97. PubMed ID: 18495445
[TBL] [Abstract][Full Text] [Related]
16. Surface analysis of sequential semi-solvent vapor impact (SAVI) for studying microstructural arrangements of poly(lactide-co-glycolide) microparticles.
Garner J; Skidmore S; Hadar J; Park H; Park K; Qin B; Wang Y
J Control Release; 2022 Oct; 350():600-612. PubMed ID: 36057396
[TBL] [Abstract][Full Text] [Related]
17. Improved drug loading via spray drying of a chalcone implant for local treatment of cutaneous leishmaniasis.
Sousa-Batista AJ; Arruda-Costa N; Rossi-Bergmann B; Ré MI
Drug Dev Ind Pharm; 2018 Sep; 44(9):1473-1480. PubMed ID: 29618227
[TBL] [Abstract][Full Text] [Related]
18. Development of PLGA-based injectable delivery systems for hydrophobic fenretinide.
Wischke C; Zhang Y; Mittal S; Schwendeman SP
Pharm Res; 2010 Oct; 27(10):2063-74. PubMed ID: 20668921
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical characterization of spray-dried PLGA/PEG microspheres, and preliminary assessment of biological response.
Javiya C; Jonnalagadda S
Drug Dev Ind Pharm; 2016 Sep; 42(9):1504-14. PubMed ID: 26902521
[TBL] [Abstract][Full Text] [Related]
20. Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.
Kusonwiriyawong C; Lipipun V; Vardhanabhuti N; Zhang Q; Ritthidej GC
Pharm Res; 2013 Jun; 30(6):1677-97. PubMed ID: 23483441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
